Proteomics

Dataset Information

0

The Checkpoint Inhibitor PD-1H/VISTA Controls Osteoclast-Mediated Multiple Myeloma Bone Disease


ABSTRACT: Multiple myeloma (MM) bone disease is characterized by the development of osteolytic bone lesions. Recent work identified matrix metalloproteinase 13 (MMP-13) as a novel MM-derived fusogen that, in turn, induces osteoclast activation independent of its proteolytic activity. While the mechanism by which the metalloprotease signals osteoclasts has remained the subject of conjecture, we now identify the checkpoint protein, programmed death-1 homolog (PD-1H/VISTA), as the bona fide MMP-13 receptor expressed on both pre- and mature osteoclasts. Silencing PD-1H or using Pd-1h-/- bone marrow cells abrogates the MMP-13-induced upregulation of ERK1/2-NFATc1-DC-STAMP signaling, the induction of osteoclast fusion and the increase in bone-resorptive activity. Further studies revealed that the intracellular domain of PD-1H interacts with the actin cytoskeleton of OCLs and plays a necessary role in supporting c-Src activation as well as sealing zone formation. The critical role of PD-1H in the development of lytic bone lesions in MM was confirmed using a Pd-1h-/- myeloma bone disease mouse model wherein MM cells injected into Pd-1h-/-Rag2-/- results in attenuated bone destruction relative to Pd-1hwtRag2-/- mice. Our findings identify a novel role for PD-1H in bone biology outside of its known immunoregulatory functions and suggest that targeting the MMP-13/PD-1H axis may represent a novel approach for the treatment of MM-associated osteolysis.

INSTRUMENT(S): Synapt G2 HDMS, Q Exactive HF

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Suzanne Lentzsch   Lewis M. Brown  

PROVIDER: MSV000089119 | MassIVE | Thu Mar 24 07:46:00 GMT 2022

REPOSITORIES: MassIVE

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-12-15 | GSE108159 | GEO
2017-01-19 | GSE93745 | GEO
2022-07-05 | PXD032934 | Pride
2012-05-22 | GSE27372 | GEO
2020-12-02 | GSE141260 | GEO
2019-06-27 | GSE133346 | GEO
2018-06-01 | GSE111651 | GEO
2023-03-17 | GSE205644 | GEO
2012-05-21 | E-GEOD-27372 | biostudies-arrayexpress
2024-04-10 | GSE234642 | GEO